Intelligent Bio Solutions, Inc. (INBS)
1.52
-0.01
(-0.65%)
USD |
NASDAQ |
Oct 12, 12:02
Intelligent Bio Solutions Gross Profit Margin (Quarterly) : 21.68% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 21.68% |
| March 31, 2026 | 23.10% |
| December 31, 2025 | 19.83% |
| September 30, 2025 | 19.33% |
| June 30, 2025 | 4.18% |
| March 31, 2025 | 5.41% |
| December 31, 2024 | -13.51% |
| September 30, 2024 | 5.32% |
| Date | Value |
|---|---|
| June 30, 2024 | 0.00% |
| March 31, 2024 | -17.04% |
| December 31, 2023 | -11.92% |
| September 30, 2023 | -9.45% |
| June 30, 2023 | -27.08% |
| March 31, 2023 | -80.05% |
| December 31, 2022 | -43.20% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Sanara MedTech, Inc. | 90.76% |
| Anteris Technologies Global Corp. | 30.43% |
| 20/20 Biolabs, Inc. | 41.71% |
| Quest Diagnostics, Inc. | 32.53% |
| Labcorp Holdings, Inc. | 27.71% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -200.0% |
| Return on Assets | -98.80% |
| Return on Invested Capital | -159.9% |
| Profit Margin (Quarterly) | -341.9% |
| Operating Margin (Quarterly) | -367.5% |
| Return on Net Operating Assets | -190.6% |